A Nationwide Study on the Incidence of Breast Cancer in Korean Women with Osteoporosis Receiving Raloxifene Treatment

PURPOSE: Raloxifene is a selective estrogen receptor modulator (SERM), and raloxifene treatment for osteoporosis is reimbursable under the Korean National Health Insurance. Evidence suggests that SERMs use reduces the risk of breast cancer in Asian population. Herein, we retrospectively investigated...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Breast Cancer
Huvudupphovsmän: Lee, Jihyoun, Lee, Ji Sung, Lee, Jong Eun, Kim, Zisun, Han, Sun Wook, Hur, Sung Mo, Choi, Young Jin, Park, Sungmin
Materialtyp: Artigo
Språk:Inglês
Publicerad: Korean Breast Cancer Society 2021
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250100/
https://ncbi.nlm.nih.gov/pubmed/34128366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2021.24.e28
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk